Reviva Pharmaceuticals Valuation
| RVPH Stock | USD 1.09 0.04 3.54% |
Today, the company appears to be undervalued. Reviva Pharmaceuticals holds a recent Real Value of $3.93 per share. The prevailing price of the company is $1.09. Our model determines the value of Reviva Pharmaceuticals from analyzing the company fundamentals such as Shares Owned By Institutions of 29.40 %, return on equity of -17.95, and Shares Outstanding of 46.58 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Reviva Pharmaceuticals' valuation include:
Undervalued
Today
Please note that Reviva Pharmaceuticals' price fluctuation is risky at this time. Calculation of the real value of Reviva Pharmaceuticals is based on 3 months time horizon. Increasing Reviva Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Reviva Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Reviva Stock. However, Reviva Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.09 | Real 3.93 | Target 12.57 | Hype 1.05 | Naive 1.21 |
The intrinsic value of Reviva Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Reviva Pharmaceuticals' stock price.
Estimating the potential upside or downside of Reviva Pharmaceuticals Holdings helps investors to forecast how Reviva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Reviva Pharmaceuticals more accurately as focusing exclusively on Reviva Pharmaceuticals' fundamentals will not take into account other important factors: When choosing an evaluation method for Reviva Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Reviva Pharmaceuticals Cash |
|
Reviva Valuation Trend
Reviva Pharmaceuticals' real value analysis enables investors to forecast the earnings more efficiently. Using both Reviva Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Reviva Pharmaceuticals Total Value Analysis
Reviva Pharmaceuticals Holdings is at this time projected to have valuation of 45.3 M with market capitalization of 50.77 M, debt of 17.98 M, and cash on hands of 23.19 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Reviva Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
45.3 M | 50.77 M | 17.98 M | 23.19 M |
Reviva Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Reviva is to check how much profit was generated for every dollar of assets it reports. Reviva Pharmaceuticals holds a negative application of assets of -3.28 pct., losing $0.0328 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Reviva Pharmaceuticals Holdings shows how discouraging it operates for each dollar spent on its assets.Reviva Pharmaceuticals Ownership Allocation
Reviva Pharmaceuticals owns a total of 46.58 Million outstanding shares. Reviva Pharmaceuticals holds significant amount of outstanding shares owned by insiders and institutional investors . Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Reviva Pharmaceuticals Profitability Analysis
Net Loss for the year was (39.26 M) with profit before overhead, payroll, taxes, and interest of 0.About Reviva Pharmaceuticals Valuation
An absolute valuation paradigm, as applied to Reviva Stock, attempts to find the value of Reviva Pharmaceuticals based on its fundamental and basic technical indicators. By analyzing Reviva Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Reviva Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reviva Pharmaceuticals. We calculate exposure to Reviva Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Reviva Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -652.3 K | -684.9 K |
Reviva Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 23.8 M |
Reviva Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Reviva Pharmaceuticals Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Reviva we look at many different elements of the entity such as Reviva's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Reviva Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Reviva Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Reviva Pharmaceuticals' worth.Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |